Clearmind Medicine (CMND) Cash & Equivalents (2021 - 2026)
Clearmind Medicine's Cash & Equivalents was $11.42 million in fiscal Q2 2026 (quarter ended Apr 30, 2026), up 155.2% from $4.47 million a year earlier and up 23.3% from the prior quarter.
Powered by 
Analysis
Clearmind Medicine (CMND) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2024 (ended Oct 31, 2024), Cash & Equivalents at Clearmind Medicine came in at $6.57 million, up 21.1% from FY2023.
- Cash & Equivalents shows a four-year compound annual growth rate of 127.5% (FY2020 to FY2024).
- In earlier fiscal years, Cash & Equivalents was $5.43 million in FY2023 (+61.1%), $3.37 million in FY2022 (unchanged), $3.37 million in FY2021 and $245,355 in FY2020.
- The fiscal Q2 2026 figure marks the highest quarterly Cash & Equivalents in data going back to fiscal Q4 2021.
- Compared with a year earlier, Cash & Equivalents was higher in four of the last seven quarters, with growth averaging 28.2%.
- The best year-over-year quarter for Cash & Equivalents over five years was fiscal Q3 2023 (growth of 897.2%); the worst was fiscal Q4 2022 (a decline of 96.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Clearmind Medicine | 9,023.39 | 9,023.39 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 11.42 Mn |
| Jan 31, 2026 | 9.26 Mn |
| Jul 31, 2025 | 3.50 Mn |
| Apr 30, 2025 | 4.47 Mn |
| Jan 31, 2025 | 5.78 Mn |
| Oct 31, 2024 | 6.57 Mn |
| Jul 31, 2024 | 7.68 Mn |
| Apr 30, 2024 | 8.31 Mn |
| Jan 31, 2024 | 9.29 Mn |
| Oct 31, 2023 | 5.43 Mn |
| Jul 31, 2023 | 3.85 Mn |
| Apr 30, 2023 | 5.25 Mn |
| Jan 31, 2023 | 3.37 Mn |
| Oct 31, 2022 | 132,334.92 |
| Jul 31, 2022 | 385,819.00 |
| Jan 31, 2022 | 2.22 Mn |
| Oct 31, 2021 | 3.66 Mn |
API Access
Clearmind Medicine Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CMND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CMND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CMND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();